| PPG |
Report |
Operating diluted EPS |
IN-LINE |
pred ~$2.26 vs. cons $2.244 |
MEDIUM |
| PPG |
Report |
Net sales |
IN-LINE |
pred ~$4.37B vs. cons $4.356B |
MEDIUM |
| PPG |
Report |
Organic sales growth |
BEAT |
pred ~2.1% vs. cons 1.98% |
LOW |
| PPG |
Guide |
FY2026 adjusted EPS ($7.70–$8.10 official range) |
UNCHANGED |
guide midpoint ~$7.90 vs. cons $7.869 |
MEDIUM |
| PPG |
Guide |
Q3 EPS / H2 margin commentary |
UNCHANGED |
guide ~H2 improvement vs. cons Q3 EPS $2.118 |
LOW |
| PPG |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
LOW |
| PPG |
Return |
5-day cumulative residual |
-4.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — maintained FY guidance likely leaves forward estimates static after a rich stock run |
LOW |